Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis
Samer Gawrieh, Srinivasan Dasarathy, Wanzhu Tu, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 5, pp. 684-693
Closed Access | Times Cited: 18

Showing 18 citing articles:

Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement
Brian P. Lee, Katie Witkiewitz, Jessica L. Mellinger, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 9, pp. 626-645
Open Access | Times Cited: 19
Inflammation in Alcohol-Associated Hepatitis: Pathogenesis and Therapeutic Targets
Dechun Feng, Seonghwan Hwang, Adrien Guillot, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 18, Iss. 3, pp. 101352-101352
Open Access | Times Cited: 8
Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives
Mengyao Yan, Shuli Man, Long Ma, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 620-648
Open Access | Times Cited: 6
Acute on chronic liver failure
Jonel Trebicka, Michael Praktiknjo, Kai‐Henrik Peiffer, et al.
Deutsches Ärzteblatt international (2025)
Closed Access
Larsucosterol for the Treatment of Alcohol-Associated Hepatitis
Mitchell Shiffman, Ben L. Da, Aparna Goel, et al.
NEJM Evidence (2025) Vol. 4, Iss. 2
Closed Access
Longitudinal paired liver biopsies and transcriptome profiling in alcohol-associated hepatitis reveal dynamic changes in cellular senescence
Daniel Rodrigo‐Torres, Alastair M. Kilpatrick, Sofía Ferreira-González, et al.
Gut (2025), pp. gutjnl-334094
Closed Access
Alcohol-associated liver disease: Emerging therapeutic strategies
Benjamin H. Mullish, Mark Thursz
Hepatology (2024) Vol. 80, Iss. 6, pp. 1372-1389
Closed Access | Times Cited: 3
Acute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisone
Kavish R. Patidar, Wanzhu Tu, Thomas G. Cotter, et al.
Hepatology (2024)
Closed Access | Times Cited: 3
Targeting IL-1 in severe alcohol-related hepatitis: How many frogs will we need to kiss to find an effective therapy?
Mark Thursz, Philippe Mathurin
Journal of Hepatology (2024) Vol. 80, Iss. 5, pp. 678-680
Closed Access | Times Cited: 1
Research Priorities and Future Landscape of Clinical Trials in Alcohol-Associated Liver Disease
Anand V. Kulkarni, Ashwani K. Singal, Patrick S. Kamath
Clinics in Liver Disease (2024) Vol. 28, Iss. 4, pp. 831-851
Closed Access | Times Cited: 1
Letter: Association of myokines with disease progression and outcomes in patients with alcohol‐associated liver disease
Jianyu Lv, Yize Ying, Chenfei Du
Alimentary Pharmacology & Therapeutics (2024)
Closed Access | Times Cited: 1
Advances in the management of alcohol-associated liver disease
Ahmad Anouti, Thomas Kerr, Mack C. Mitchell, et al.
Gastroenterology report (2023) Vol. 12
Open Access | Times Cited: 2
Current Medical Treatment of Alcohol-Associated Liver Disease
Josiah Hardesty, Craig J. McClain
Clinics in Liver Disease (2024) Vol. 28, Iss. 4, pp. 731-745
Closed Access
Expedited liver transplantation as first‐line therapy for severe alcohol hepatitis: ELFSAH; deferring corticosteroids in the sickest subset of patients
Nabeeha Mohy‐ud‐din, Fei‐Pi Lin, Vikrant Rachakonda, et al.
Clinical Transplantation (2024) Vol. 38, Iss. 7
Open Access
The pharmacological management of alcohol-related cirrhosis: what’s new?
Nipun Verma, Ashwin P. Vinod, Ashwani K. Singal
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 14, pp. 1923-1941
Closed Access
Infections in decompensated cirrhosis: Pathophysiology, management, and research agenda
J Ferguson, Elsa Solà, María Alejandra Pérez, et al.
Hepatology Communications (2024) Vol. 8, Iss. 10
Open Access
Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models
Hong Xiao, Shuo Huang, He Jiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
The pyruvate dehydrogenase kinase inhibitor dichloroacetate mitigates alcohol-induced hepatic inflammation and metabolic disturbances in mice
Jianguo Wu, Emily Huang, Megan R. McMullen, et al.
Hepatology Communications (2024) Vol. 8, Iss. 12
Open Access
Page 1

Scroll to top